CASI Pharmaceuticals, Inc.
CASI
$1.94
$0.22713.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.69% | 63.54% | -35.28% | -36.09% | -13.56% |
| Total Receivables | 37.71% | 43.89% | 27.66% | -40.17% | -13.02% |
| Inventory | -59.37% | -11.56% | -5.23% | -2.88% | 79.81% |
| Prepaid Expenses | 27.22% | 7.53% | 5.34% | -21.72% | 25.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.07% | 26.77% | -13.81% | -27.28% | 2.11% |
|
|
|||||
| Total Current Assets | -16.07% | 26.77% | -13.81% | -27.28% | 2.11% |
| Net Property, Plant & Equipment | -8.38% | 20.94% | -5.48% | -6.77% | 9.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -78.69% | -17.75% | -16.38% | -11.69% | 573.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.38% | 1.45% | -1.42% | -8.36% | -52.57% |
| Total Assets | -15.63% | 24.08% | -11.62% | -22.93% | 1.40% |
|
|
|||||
| Total Accounts Payable | 54.37% | 122.73% | 35.85% | -86.86% | 73.16% |
| Total Accrued Expenses | -34.75% | 215.62% | -48.36% | 11.40% | -22.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 147.32% | 53.80% | 12.16% | -48.92% | 41.42% |
|
|
|||||
| Total Current Liabilities | 147.32% | 53.80% | 12.16% | -48.92% | 41.42% |
| Long-Term Debt | -- | 3.56% | -0.65% | -1.64% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.31% | 24.07% | -16.82% | 11.16% | 15.87% |
| Total Liabilities | 4.13% | 17.80% | -0.69% | -16.75% | 114.77% |
|
|
|||||
| Common Stock & APIC | 0.10% | 1.89% | 0.41% | 0.11% | 0.01% |
| Retained Earnings | -2.10% | -1.24% | -1.04% | -1.44% | -0.79% |
| Treasury Stock & Other | 12.79% | -0.03% | -21.81% | 0.89% | 3.73% |
| Total Common Equity | -86.63% | 53.50% | -41.68% | -35.99% | -16.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -86.63% | 53.50% | -41.68% | -35.99% | -16.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -86.63% | 53.50% | -41.68% | -35.99% | -52.09% |
|
|
|||||